...
机译:溶瘤腺病毒和肿瘤靶向免疫调节治疗改善自体癌症疫苗接种
Univ Texas MD Anderson Canc Ctr Brain Tumor Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Brain Tumor Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Brain Tumor Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Stem Cell Transplantat &
Cellular Therapy Houston TX 77030;
Univ Texas MD Anderson Canc Ctr Dept Genom Med Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Immunol Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Dept Biostat Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Brain Tumor Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Inst Appl Canc Sci Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Brain Tumor Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Brain Tumor Ctr Houston TX 77030 USA;
机译:溶瘤腺病毒和肿瘤靶向免疫调节治疗改善自体癌症疫苗接种
机译:溶瘤腺病毒ZD55-IL-24在具有免疫能力的小鼠中针对胰腺癌的癌症靶向基因-病毒治疗
机译:CEA启动子调节溶瘤腺病毒介导的Hsp70在胰腺癌免疫基因治疗中的表达
机译:免疫调节抗性治疗对断奶猪疫苗接种疫苗的影响
机译:溶瘤腺病毒载体和癌症治疗:在免疫能力强的叙利亚仓鼠模型中评估宿主免疫系统在载体抗肿瘤功效和毒性中的作用
机译:溶瘤腺病毒和靶向肿瘤的免疫调节疗法可改善自体癌症疫苗接种
机译:溶瘤腺病毒和肿瘤靶向免疫调节治疗改善自体癌症疫苗接种